MELOTTI, Paola Maria
 Distribuzione geografica
Continente #
EU - Europa 4.738
NA - Nord America 4.007
AS - Asia 3.194
SA - Sud America 457
AF - Africa 45
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.455
Nazione #
US - Stati Uniti d'America 3.894
RU - Federazione Russa 1.890
SG - Singapore 1.181
CN - Cina 1.170
GB - Regno Unito 1.100
BR - Brasile 382
IT - Italia 375
SE - Svezia 289
DE - Germania 275
VN - Vietnam 250
HK - Hong Kong 230
FR - Francia 202
IE - Irlanda 201
FI - Finlandia 191
KR - Corea 79
CA - Canada 77
TR - Turchia 50
UA - Ucraina 42
IN - India 40
JP - Giappone 40
ID - Indonesia 38
PL - Polonia 30
NL - Olanda 29
BE - Belgio 28
AR - Argentina 27
ES - Italia 27
MX - Messico 25
AT - Austria 23
IQ - Iraq 18
BD - Bangladesh 13
EC - Ecuador 13
PK - Pakistan 12
ZA - Sudafrica 12
IR - Iran 11
UZ - Uzbekistan 11
VE - Venezuela 10
PY - Paraguay 9
CZ - Repubblica Ceca 7
IL - Israele 7
LT - Lituania 7
AU - Australia 6
BJ - Benin 6
PE - Perù 6
TG - Togo 6
CO - Colombia 5
JO - Giordania 5
NP - Nepal 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
EG - Egitto 4
LV - Lettonia 4
MA - Marocco 4
NZ - Nuova Zelanda 4
SA - Arabia Saudita 4
CL - Cile 3
KZ - Kazakistan 3
LU - Lussemburgo 3
PT - Portogallo 3
TN - Tunisia 3
AL - Albania 2
CH - Svizzera 2
DZ - Algeria 2
GE - Georgia 2
KG - Kirghizistan 2
MY - Malesia 2
NI - Nicaragua 2
PH - Filippine 2
PS - Palestinian Territory 2
TT - Trinidad e Tobago 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CD - Congo 1
CG - Congo 1
CM - Camerun 1
CY - Cipro 1
DK - Danimarca 1
EU - Europa 1
HN - Honduras 1
HR - Croazia 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LY - Libia 1
NE - Niger 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PG - Papua Nuova Guinea 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 12.451
Città #
Southend 964
Moscow 650
Chandler 581
Singapore 567
Dallas 389
Ashburn 323
Jacksonville 291
Woodbridge 289
Hong Kong 228
Ann Arbor 220
Beijing 206
Dublin 197
Verona 165
Houston 152
New York 133
Munich 98
Jinan 91
Wilmington 83
Los Angeles 72
Princeton 72
Lawrence 71
Nanjing 71
Shenyang 70
Dong Ket 61
Ho Chi Minh City 61
The Dalles 60
Tianjin 45
Turku 45
Helsinki 40
Hebei 35
Seoul 35
Nanchang 33
Redondo Beach 33
Buffalo 32
Guangzhou 32
Ningbo 31
Haikou 30
Tokyo 30
Santa Clara 29
Jakarta 28
São Paulo 28
Brussels 27
Hanoi 27
Zhengzhou 27
Changsha 26
Lancaster 26
Hangzhou 24
Jiaxing 24
Montreal 24
Taiyuan 24
Sindelfingen 23
Taizhou 23
London 21
Warsaw 21
Milan 20
Toronto 20
Brooklyn 19
San Francisco 19
Seattle 19
Stockholm 19
Columbus 18
Fairfield 18
Vienna 18
Falls Church 17
Boardman 16
Council Bluffs 16
Orem 16
Chennai 15
Poplar 15
Boston 14
Madrid 14
Nuremberg 14
Phoenix 14
Frankfurt am Main 13
Lappeenranta 13
San Jose 13
Amsterdam 12
Bologna 12
Belo Horizonte 11
Da Nang 11
Elora 11
Norwalk 11
Rio de Janeiro 11
Tashkent 11
Washington 11
Atlanta 10
Chicago 10
Redwood City 10
Rome 10
Brasília 9
Johannesburg 9
Kent 9
Mexico City 9
Redmond 9
Denver 8
Dongguan 8
Curitiba 7
Lanzhou 7
Manchester 7
Riva del Garda 7
Totale 7.578
Nome #
Development of FT-IR microspectroscopy for pre-clinical and clinical applications 320
Functional Evaluation of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in human monocytes 259
Detection of CFTR protein in human leukocytes by flow cytometry. 248
Defective CFTR expression and function are detectable in blood monocytes: development of a new blood test for cystic fibrosis. 246
Virulence and antibiotic resistance of Achromobacter spp. isolates from chronic and occasional lung infection in cystic fibrosis patients 230
Azithromycin (AZM) decreases Glutathione-S-Transferase (GST) -T1 expression and activity in CF airway epithelial cells. 227
Analysis of CFTR function in human monocytes 226
Analysis of proteins released from Pseudomonas aeruginosa clinical and laboratory strains: effects of azithromycin 214
Azithromycin (AZM) decreases Glutathione-S-Transferase (GST) - T1 expression and activity in CF airway epithelial cells 210
P139 Hypermutation as an evolutionary mechanism for Achromobacter spp. in cystic fibrosis lung infection 205
Azithromicin decreases elevated glutathione-S-transferase T1 (GSTT1) and M1 (GSTM1) expression and activity in cystic fibrosis airways epithelial cells 198
Analysis of Pseudomonas Aeuginosa secretome: consequences of oxygen limitation in clinical and laboratory strains 198
Biogenic selenium nanoparticles: characterization, antimicrobial activity and effects on human dendritic cells and fibroblasts 197
Combining standardized and new CFTR functional tests for diagnosis 194
An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses 191
MudPIT analysis of released proteins in Pseudomonas aeruginosa laboratory and clinical strains in relation to pro-inflammatory effects 189
WS18.3 A combination of CFTR functional tests supporting drug development and diagnosis: the contribution of intestinal epithelial organoids 186
Proteins released from Pseudomonas aeruginosa (Pa) referent and clinical strains under microaerobiosis and their effects on cystic fibrosis airways 185
Mutations of Cystic Fibrosis Transmembrane Conductance Regulator Gene Cause a Monocyte-Selective Adhesion Deficiency. 184
An interactive computer program can effectively educate potential users of cystic fibrosis carrier tests. 182
Impaired CFTR function in mild cystic fibrosis associated with the S977F/T5TG12complex allele in trans with F508del mutation. 178
New potential biomarkers for the management of cystic fibrosis: measurements of CFTR expression & function in human leukocytes. 174
Impact of polymorphism of Multidrug Resistance-associated Protein 1 (ABCC1) gene on the severity of cystic fibrosis. 174
IMPAIRED CFTR FUNCTION IN MILD CF ASSOCIATED WITH THE S977F/T5TG12 COMPLEX ALLELE 174
14 Standardized protocol for ratiometric measurement of b-adrenergic/cholinergic sweating in human sweat glands 173
Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice 173
Protein Tyrosine Phosphatase Gamma (PTPgamma) is a Novel Leukocyte Marker Highly Expressed by CD34 Precursors 169
ePS01.7 Supporting diagnosis with a combination of standardized and new CFTR functional tests 169
22 Testing flow cytometry to detect CFTR expression recovery after drug treatment in epithelial cell lines 169
New clinical diagnostic procedures for cystic fibrosis in Europe. 168
AZITHROMYCIN EFFECT ON LUNG INFLAMMATION INDUCED BY PSEUDOMONAS AERUGINOSA RELEASED PROTEASES AS SHOWN BY IN VIVO IMAGING IN IL-8 TRANSIENTLY TRANSGENIZED MICE 168
Poster Session Abstracts 168
In vivo monitoring of lung inflammation in CFTR-deficient mice 167
Impaired CTFR function in mild CF associated with the S977F/T5TG12 complex allele. 166
20 In vivo monitoring of lung inflammation in CFTR–/– mice 164
DEVELOPMENT OF A CF, IL-8 TRANSGENIC MOUSE MODEL FOR THE IN VIVO LONG-TERM MONITORING OF LUNG INFLAMMATION 162
Intestinal epithelial organoids contribute to combination of CFTR functional tests supporting drug development and diagnosis 157
Whole blood fatty acid analysis with micromethod in cystic fibrosis and pulmonary disease. 151
Poster Session Abstracts 149
Effects of azithromycin on glutathione S-transferases in cystic fibrosis airway cells 148
Poster Session Abstracts 148
Achromobacter spp. adaptation in cystic fibrosis infection and candidate biomarkers of antimicrobial resistance 147
Mobilome analysis of Achromobacter spp. isolates from chronic and occasional lung infection in cystic fibrosis patients 146
Cystic fibrosis transmembrane conductance regulator functional evaluations in a G542X+/- IVS8Tn:T7/9 patient with acute recurrent pancreatitis 145
HLA-G expression and regulation during Pseudomonas aeruginosa infection in cystic fibrosis patients 143
Toothbrushes may convey bacteria to the cystic fibrosis lower airways 143
Effects of high altitude on eosinophil protein X (EPX) serum levels and specific IgE for pteronyssinus (Dpt) and farinae (Df) in asthmatic children 142
Ratiometric sweat secretion optical test in cystic fibrosis, carriers and healthy subjects 139
Optical Measurements of Sweat for in Vivo Quantification of CFTR Function in Individual Sweat Glands 137
A PI3Kγ mimetic peptide triggers CFTR gating, bronchodilation, and reduced inflammation in obstructive airway diseases 137
Azithromycin Attenuates Pseudomonas-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium 135
In vivo imaging of the lung inflammatory response to Pseudomonas aeruginosa and its modulation by azithromycin 134
Eosinophil activation in bronchial asthma: the role of adhesion molecules (ß1 and ß2 integrins) 133
Real-Life Experience with CFTR Modulators Shows Correction of LAD-IV Phenotype in Cystic Fibrosis 132
Guideline on the design and conduct of cystic fibrosis clinical trials: the European Cystic Fibrosis Society-Clinical Trials Network (ECFS-CTN). 132
Genomic characterization of Achromobacter species isolates from chronic and occasional lung infection in cystic fibrosis patients 131
Poster Session Abstracts 129
Longitudinal monitoring of sinonasal and oral bacterial reservoirs to prevent chronic lung infection in people with cystic fibrosis 127
MOLECULAR IMAGING OF THE ANTI-INFLAMMATORY EFFECTS OF AZITHROMYCIN IN THE LUNG 126
The identification of cystic fibrosis (CF) cells and their pharmacological correction by mid-infrared microspectroscopy and unsupervised data analysis methods 123
Impact of the polymorphic variant 5 FR/G-260C in the Multidrug Resistance-associate Protein-1 gene on severity of cystic fibrosis 121
Identification of Potential Leukocyte Biomarkers Related to Drug Recovery of CFTR: Clinical Applications in Cystic Fibrosis 121
IMPACT OF POLYMORPHIC-794 CATT REPEATS OF MACROPHAGE MIGRATION INHIBITORY FACTOR PROMOTER ON SEVERITY OF CF 118
In silico analysis and theratyping of an ultra-rare CFTR genotype (W57G/A234D) in primary human rectal and nasal epithelial cells 113
CFTR function is impaired in a subset of patients with pancreatitis carrying rare CFTR variants 110
Receptor Protein Tyrosine Phosphatase gamma (Ptpg) regulates hematopoietic differentiation 108
CFTR Modulators Rescue the Activity of CFTR in Colonoids Expressing the Complex Allele p.[R74W;V201M;D1270N]/dele22_24 106
Oxidative stress and antioxidant therapy in cystic fibrosis 105
In Vivo Inflammation Caused by Achromobacter spp. Cystic Fibrosis Clinical Isolates Exhibiting Different Pathogenic Characteristics 104
PROTEOMIC ANALYSIS OF PROTEINS RELEASED FROM PSEUDOMONAS AERUGINOSA CLINICAL AND LABORATORY STRAINS: EFFECTS OF AZITHROMYCIN 102
Functional rescue of CFTR in rectal organoids from patients carrying R334W variant by CFTR modulators and PDE4 inhibitor Roflumilast 101
PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients 98
RELEVANCE OF HLA-G IN CF 98
STANDARDIZATION OF RATIOMETRIC MEASUREMENT OF BETA ADRENERGIC/CHOLINERGIC SWEATING IN HUMAN SWEAT GLANDS 98
When and how ruling out cystic fibrosis in adult patients with bronchiectasis 96
Relevance of oxygen limitation on pseudomonas aeruginosa strains: Effects on released proteins expression 94
Efficacy and safety of ataluren in patients with nonsense-mutation cystic fibrosis not receiving chronic inhaled aminoglycosides: the international, randomized, double-blind, placebo-controlled Ataluren Confirmatory Trial in Cystic Fibrosis (ACT CF). 89
The role of macrophages and their scavenger receptors in cystic fibrosis 86
Evaluation of the response to elexacaftor-tezacaftor-ivacaftor of the rare CFTR variants L383S, I507del, L1065P and R1066H in intestinal organoid-derived epithelial monolayers 83
Adenine base editing with engineered virus-like particles rescues the CFTR mutation G542X in patient-derived intestinal organoids 83
Theratyping of the Rare CFTR Genotype A559T in Rectal Organoids and Nasal Cells Reveals a Relevant Response to Elexacaftor (VX-445) and Tezacaftor (VX-661) Combination 80
Organoid Technology and Its Role for Theratyping Applications in Cystic Fibrosis 70
Theratyping of the Rare CFTR Variants E193K and R334W in Rectal Organoid-Derived Epithelial Monolayers 60
Totale 12.583
Categoria #
all - tutte 41.906
article - articoli 22.746
book - libri 0
conference - conferenze 19.160
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.812


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021303 0 0 0 0 0 49 15 31 25 2 81 100
2021/2022741 88 241 4 43 45 19 8 28 27 28 52 158
2022/20231.472 113 175 109 267 115 359 17 79 171 8 40 19
2023/2024824 52 57 51 82 79 158 33 54 37 45 126 50
2024/20252.178 98 126 82 370 80 80 177 74 308 153 245 385
2025/20264.207 404 316 412 1.023 1.654 398 0 0 0 0 0 0
Totale 12.583